Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,047.55INR
6:16am EDT
Price Change (% chg)

Rs-30.10 (-1.45%)
Prev Close
Rs2,077.65
Open
Rs2,069.00
Day's High
Rs2,101.85
Day's Low
Rs2,037.85
Volume
16,387
Avg. Vol
17,339
52-wk High
Rs2,150.90
52-wk Low
Rs1,528.00

REDY.BO

Chart for REDY.BO

About

Dr. Reddy’s Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active... (more)

Overall

Beta: 0.64
Market Cap (Mil.): Rs352,971.19
Shares Outstanding (Mil.): 169.84
Dividend: 15.00
Yield (%): 0.66

Financials

  REDY.BO Industry Sector
P/E (TTM): 24.41 35.66 35.83
EPS (TTM): 85.16 -- --
ROI: -- 19.36 18.72
ROE: -- 20.07 19.54
Search Stocks

Latest News about REDY.BO

India's NSE index hits 28-month high

MUMBAI, May 11 - India's NSE index rose marginally on Saturday to its highest level since January 2011, led by Dr. Reddy's Laboratories Ltd, and ITC Ltd ahead of their quarterly earnings releases next week. The broader NSE index rose 0.21 percent, or 12.50 points, to end at 6,107.25. The benchmark BSE index rose 0.20 percent, or 39.70 points, to end at 20,122.32. Shares in Dr. Reddy's Laboratories stock rose 3.85 percent, while ITC ended 0.28 percent higher. The market was

11 May 2013

Dr Reddy's launches prostate cancer drug in India

MUMBAI, Dec 7 - Dr. Reddy's Laboratories Ltd , India's No. 2 drugmaker by sales, said it has launched Pamorelin, a drug to treat prostate cancer, in India.

07 Dec 2012
» More REDY.BO News

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - DR REDDYS LABORATORIES LIMITED (DRREDDY-IN)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Dr. Reddy's Labs ADS
Provider: S&P Capital IQ – STARS Reports
$115.00
Buy
Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
DR REDDY S LABORATORIES INC (RDY) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks